Invivyd (IVVD) Selling, General & Administrative (2021 - 2026)
Invivyd's Selling, General & Administrative was $29.47 million in Q2 2026, up 77.6% from $16.59 million a year earlier.
Powered by 
Analysis
Invivyd (IVVD) Selling, General & Administrative (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, Invivyd's Selling, General & Administrative was $79.65 million through Jun 30, 2026, up 31.2% year-over-year; for FY2025, it was $66.93 million, up 5.6% from FY2024.
- Selling, General & Administrative has now increased for four consecutive years, with a five-year compound annual growth rate of 83.6% (FY2020 to FY2025).
- In earlier years, Selling, General & Administrative was $63.39 million in FY2024 (+29.0%), $49.13 million in FY2023 (+4.4%), $47.04 million in FY2022 (+28.8%) and $36.52 million in FY2021.
- The Q2 2026 figure marks the highest quarterly Selling, General & Administrative in data going back to Q1 2021.
- Compared with a year earlier, Selling, General & Administrative was higher in five of the last seven quarters, with growth averaging 15.6%.
- The best year-over-year quarter for Selling, General & Administrative over five years was Q1 2022 (growth of 136.7%); the worst was Q2 2023 (a decline of 30.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Invivyd | 241.70 Mn | -264.94 Mn | 13.01 Mn | 29.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.47 Mn |
| Dec 31, 2025 | 18.57 Mn |
| Sep 30, 2025 | 15.02 Mn |
| Jun 30, 2025 | 16.59 Mn |
| Mar 31, 2025 | 16.75 Mn |
| Dec 31, 2024 | 14.42 Mn |
| Sep 30, 2024 | 12.96 Mn |
| Jun 30, 2024 | 21.09 Mn |
| Mar 31, 2024 | 14.93 Mn |
| Dec 31, 2023 | 15.09 Mn |
| Sep 30, 2023 | 12.89 Mn |
| Jun 30, 2023 | 10.11 Mn |
| Mar 31, 2023 | 11.05 Mn |
| Dec 31, 2022 | 10.52 Mn |
| Sep 30, 2022 | 13.20 Mn |
| Jun 30, 2022 | 14.62 Mn |
| Mar 31, 2022 | 8.70 Mn |
| Dec 31, 2021 | 14.66 Mn |
| Sep 30, 2021 | 11.05 Mn |
| Jun 30, 2021 | 7.12 Mn |
API Access
Invivyd Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=IVVD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "IVVD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=IVVD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();